SARS-CoV-2 Antibody Test

Frequently asked questions: 

1. Will I develop antibodies after vaccination?

Throughout the pandemic, antibody tests have been used to determine whether someone was previously infected with the coronavirus. With vaccines being rolled out to all Australians, since February 2021, an increasing demand by individuals to measure for antibody presence post vaccination is anticipated. The Australian Technical Advisory Group on Immunisation (ATAGI) will confirm the booster vaccination program details the end of October 2021.

2. What is Rapid Antibody Test?

The Wondfo SARS-CoV-2 Antibody Test (lateral flow method) is a rapid point-of-care test.
■ Convenient – performed on a blood sample (e.g. finger prick)
■ Rapid – test results available in 15 minutes
■ Easy to interpret – result indicated by coloured bands
■ Can be performed in general practice – allows GPs to provide testing services without the need to refer patients to a pathology collection point.

3. What the test measures?
The Wondfo SARS-CoV-2 Antibody Test detects the presence of IgM and IgG against SARS-CoV-2.. A positive test indicates an immune response to the virus. 

4. What type of test you use?
The Wondfo SARS-CoV-2 Antibody Test is a lateral flow immunochromatographic assay.

5. What are the benefits to patients?

■ For unvaccinated patients – a second chance to test if infection has occurred, after viral particles are no longer detectable(a)
■ For travellers – potential proof of seronegative status as required for travel to some countries(b)
■ For vaccinated patients – an opportunity to check for the presence of neutralising antibodies(c)

6. What are the benefits to GPs?
■ Choice of venous blood or fingertip capillary sampling offers flexibility across a range of clinical settings
■ The ability to offer opportunistic testing as a private service

Wondfo Biotech Rapid Antibody Test (ARTG 333902)

– POC

– Professional use

– Not for self-test